Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation
Intravitreal ranibizumab therapy is widely used in treatment of subfoveal choroidal neovascularisation (CNV) in age-related macular degeneration. We wanted to study the effect of intravitreal ranibizumab therapy in peripapillary CNV. A prospective recording of treatment outcomes in twelve eyes (12 p...
| Auteurs principaux: | , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
Wiley
2011-01-01
|
| Collection: | Journal of Ophthalmology |
| Accès en ligne: | http://dx.doi.org/10.1155/2011/602729 |